RJA
ENOV icon

Raymond James & Associates’s Enovis ENOV Stock Holding History

Raymond James & Associates’s Portfolio ENOV Stock Details ENOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.44M Buy
56,692
+51,874
+1,077% +$2.31M ﹤0.01% 2109
2024
Q2 		$218K Buy
4,818
+987
+26% +$51.2K ﹤0.01% 3559
2024
Q1 		$239K Sell
3,831
-35
-0.9% -$2.09K ﹤0.01% 3517
2023
Q4 		$217K Sell
3,866
-345
-8% -$17.2K ﹤0.01% 3475
2023
Q3 		$222K Sell
4,211
-559
-12% -$32.6K ﹤0.01% 3398
2023
Q2 		$306K Buy
4,770
+248
+5% +$14.1K ﹤0.01% 3244
2023
Q1 		$242K Sell
4,522
-69
-2% -$4K ﹤0.01% 3390
2022
Q4 		$246K Sell
4,591
-25,075
-85% -$1.29M ﹤0.01% 3329
2022
Q3 		$1.37M Sell
29,666
-9,072
-23% -$492K ﹤0.01% 2204
2022
Q2 		$2.13M Sell
38,738
-14,814
-28% -$955K ﹤0.01% 1940
2022
Q1 		$3.67M Sell
53,552
-55
-0.1% -$3.92K ﹤0.01% 1737
2021
Q4 		$4.24M Buy
53,607
+15
+0% +$1.25K ﹤0.01% 1666
2021
Q3 		$4.23M Sell
53,592
-1,125
-2% -$90.4K ﹤0.01% 1602
2021
Q2 		$4.31M Sell
54,717
-1,358
-2% -$104K ﹤0.01% 1582
2021
Q1 		$4.23M Sell
56,075
-535
-0.9% -$39.2K ﹤0.01% 1530
2020
Q4 		$3.73M Sell
56,610
-39,683
-41% -$2.32M ﹤0.01% 1503
2020
Q3 		$5.2M Sell
96,293
-17,425
-15% -$957K 0.01% 1199
2020
Q2 		$5.46M Buy
113,718
+10,535
+10% +$465K 0.01% 1133
2020
Q1 		$3.52M Buy
103,183
+4,624
+5% +$254K 0.01% 1242
2019
Q4 		$6.17M Sell
98,559
-350
-0.4% -$19.8K 0.01% 1135
2019
Q3 		$4.95M Buy
98,909
+19,722
+25% +$931K 0.01% 1230
2019
Q2 		$3.82M Sell
79,187
-3,790
-5% -$182K 0.01% 1383
2019
Q1 		$4.24M Buy
82,977
+16,888
+26% +$740K 0.01% 1277
2018
Q4 		$2.38M Buy
66,089
+48,441
+274% +$2.26M ﹤0.01% 1539
2018
Q3 		$1.09M Sell
17,648
-37
-0.2% -$2.11K ﹤0.01% 2189
2018
Q2 		$933K Sell
17,685
-29,646
-63% -$1.6M ﹤0.01% 2263
2018
Q1 		$2.6M Sell
47,331
-13,362
-22% -$824K ﹤0.01% 1543
2017
Q4 		$4.14M Buy
60,693
+32,881
+118% +$2.21M 0.01% 1236
2017
Q3 		$1.99M Sell
27,812
-6,883
-20% -$479K ﹤0.01% 1652
2017
Q2 		$2.35M Sell
34,695
-2,987
-8% -$204K 0.01% 1463
2017
Q1 		$2.55M Buy
37,682
+7,889
+26% +$526K 0.01% 1386
2016
Q4 		$1.84M Sell
29,793
-1,282
-4% -$75.8K ﹤0.01% 1536
2016
Q3 		$1.68M Sell
31,075
-16,290
-34% -$821K ﹤0.01% 1567
2016
Q2 		$2.16M Buy
47,365
+13,141
+38% +$642K 0.01% 1287
2016
Q1 		$1.68M Sell
34,224
-46,500
-58% -$1.98M 0.01% 1375
2015
Q4 		$3.24M Buy
80,724
+25,093
+45% +$1.15M 0.01% 1015
2015
Q3 		$2.86M Sell
55,631
-42,502
-43% -$2.82M 0.01% 1026
2015
Q2 		$7.79M Buy
98,133
+3,357
+4% +$284K 0.03% 612
2015
Q1 		$7.79M Buy
94,776
+8,868
+10% +$743K 0.03% 551
2014
Q4 		$7.63M Buy
85,908
+18,041
+27% +$1.63M 0.04% 506
2014
Q3 		$6.66M Sell
67,867
-16,566
-20% -$1.86M 0.04% 507
2014
Q2 		$10.8M Buy
84,433
+1,089
+1% +$136K 0.07% 328
2014
Q1 		$10.2M Sell
83,344
-1,366
-2% -$157K 0.07% 311
2013
Q4 		$9.29M Buy
84,710
+291
+0.3% +$29.1K 0.07% 318
2013
Q3 		$8.21M Buy
84,419
+2,672
+3% +$246K 0.07% 322
2013
Q2 		$7.33M Buy
+81,747
New +$6.74M 0.07% 322

Other funds holding ENOV

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James & Associates's ENOV Position: Q3 2024 in Review

Raymond James & Associates increased its Enovis (ENOV) stake by 1,077% in Q3 2024, buying an estimated $2.31M and bringing the position to 56,692 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

Raymond James & Associates first reported a position in ENOV in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.8M in Q2 2014. 283 funds tracked by Wall St. Rank hold ENOV as of Q3 2024.

  • Raymond James & Associates held 56,692 shares of Enovis worth $2.44M as of Q3 2024.
  • Raymond James & Associates bought 51,874 Enovis shares in Q3 2024, an estimated $2.31M.
  • Enovis made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2109 holding.
  • Raymond James & Associates first reported a position in Enovis in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Enovis position peaked at $10.8M in Q2 2014.
  • 283 funds tracked by Wall St. Rank held Enovis as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.